Join
Live feed
·
INSIDERFilingvia Quantisnow
Day One Biopharmaceuticals Inc. logo

COO and CFO York Charles N Ii converted options into 23,375 shares and sold $70,359 worth of shares (6,065 units at $11.60), increasing direct ownership by 6% to 312,025 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DAWN (Day One Biopharmaceuticals Inc.) and more on Quantisnow.